ArticleHepatology international2023

Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan.

Chen-Hua Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.